Novartis Oncology Organizational Development Manager Salaries in New York
The average Novartis Oncology Organizational Development Manager in New York earns an estimated $106,725 annually, which includes an estimated base salary of $96,781 with a $9,944 bonus. Novartis Oncology's Organizational Development Manager compensation is $4,501 more than the US average for a Organizational Development Manager. Organizational Development Manager salaries at Novartis Oncology in New York can range from $60,000 - $145,200.
In New York, The HR Department at Novartis Oncology earns $7,269 more on average than the Legal Department.
Last updated 3 years ago.
- $96,781
- avg. base
- $9,944
- avg. bonus
Organizational Development Manager Salaries at Novartis Oncology
In New York, Organizational Development Managers earn $1,994 more than HR Managers, and $56,692 less than Directors of HR.
Compensation at Novartis Oncology by Department
In New York, The HR Department averages $7,269 more than the Legal Department, and $4,630 less than the IT Department
Organizational Development Manager Compensation by Gender (All Companies)
The average female Organizational Development Manager at companies similar size to Novartis Oncology reported making $116,859, while the average male Organizational Development Manager at similar sized companies reported making $136,237.
Organizational Development Manager Compensation by Ethnicity (All Companies)
The average Native American Organizational Development Manager at companies similar size to Novartis Oncology reported making $160,000, while the average Caucasian Organizational Development Manager at similar sized companies reported making $114,466.
How Organizational Development Managers at Novartis Oncology Rate Their Compensation
The majority of Organizational Development Managers at Novartis Oncology believe they're not compensated fairly. 100% of Organizational Development Managers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
